Literature DB >> 19399516

Experimental models of hepatocellular carcinoma: developments and evolution.

Long Wu1, Zhao-You Tang, Yan Li.   

Abstract

Hepatocellular carcinoma (HCC) is one of the most common malignancies in the world. The biological mechanisms of hepatocarcinogenesis and progression are poorly understood. Experimental models of HCC provide valuable tools to evaluate the risk factors, new treatment modalities and biologic characteristics. Under the constant evolution in model design and technology development, new experimental models continue to emerge, including spontaneous models, induced models, viral models, transplantable models, and genetically engineered models. These models are used as tools to investigate basic biological mechanisms of growth and differentiation, oncogene function, and as systems to test new diagnostic and therapeutic approaches. Each model has its own advantages and disadvantages. The progress in HCC model construction and studies are summarized in this review.

Entities:  

Mesh:

Year:  2009        PMID: 19399516     DOI: 10.1007/s00432-009-0591-7

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  120 in total

1.  Antihepatoma effect of alpha-fetoprotein antisense phosphorothioate oligodeoxyribonucleotides in vitro and in mice.

Authors:  X W Wang; J H Yuan; R G Zhang; L X Guo; Y Xie; H Xie
Journal:  World J Gastroenterol       Date:  2001-06       Impact factor: 5.742

Review 2.  Animal models of human disease. Pathology and molecular biology of spontaneous neoplasms occurring in transgenic mice carrying and expressing activated cellular oncogenes.

Authors:  P K Pattengale; T A Stewart; A Leder; E Sinn; W Muller; I Tepler; E Schmidt; P Leder
Journal:  Am J Pathol       Date:  1989-07       Impact factor: 4.307

3.  Tumorigenesis in p27/p53- and p18/p53-double null mice: functional collaboration between the pRb and p53 pathways.

Authors:  Lorna A Damo; Paul W Snyder; David S Franklin
Journal:  Mol Carcinog       Date:  2005-02       Impact factor: 4.784

4.  Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus.

Authors:  Hervé Lerat; Masao Honda; Michael R Beard; Kim Loesch; Jiaren Sun; Yan Yang; Michiari Okuda; Rainer Gosert; Shu-Yuan Xiao; Steven A Weinman; Stanley M Lemon
Journal:  Gastroenterology       Date:  2002-02       Impact factor: 22.682

5.  Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray.

Authors:  Y Li; Y Tang; L Ye; B Liu; K Liu; J Chen; Q Xue
Journal:  J Cancer Res Clin Oncol       Date:  2002-12-04       Impact factor: 4.553

6.  Characterization of cell lines established from human hepatocellular carcinoma.

Authors:  J G Park; J H Lee; M S Kang; K J Park; Y M Jeon; H J Lee; H S Kwon; H S Park; K S Yeo; K U Lee
Journal:  Int J Cancer       Date:  1995-07-28       Impact factor: 7.396

7.  Establishment and characterization of a diethylnitrosamine-initiated woodchuck hepatocyte cell line.

Authors:  H Lee; T Kawaguchi; K Nomura; T Kitagawa
Journal:  Hepatology       Date:  1987 Sep-Oct       Impact factor: 17.425

8.  Rapid development of hepatic tumors in transforming growth factor alpha transgenic mice associated with increased cell proliferation in precancerous hepatocellular lesions initiated by N-nitrosodiethylamine and promoted by phenobarbital.

Authors:  S Tamano; G T Merlino; J M Ward
Journal:  Carcinogenesis       Date:  1994-09       Impact factor: 4.944

9.  Establishment of two rat hepatoma cell strains produced by a carcinogen initiation, phenobarbital promotion protocol.

Authors:  D L Novicki; R L Jirtle; G Michalopoulos
Journal:  In Vitro       Date:  1983-03

10.  Hepatitis B surface antigen produced by a human hepatoma cell line.

Authors:  G M MacNab; J J Alexander; G Lecatsas; E M Bey; J M Urbanowicz
Journal:  Br J Cancer       Date:  1976-11       Impact factor: 7.640

View more
  15 in total

1.  Chitosan-alginate scaffold culture system for hepatocellular carcinoma increases malignancy and drug resistance.

Authors:  Matthew Leung; Forrest M Kievit; Stephen J Florczyk; Omid Veiseh; Jennifer Wu; James O Park; Miqin Zhang
Journal:  Pharm Res       Date:  2010-06-29       Impact factor: 4.200

2.  Liver engraftment potential of hepatic cells derived from patient-specific induced pluripotent stem cells.

Authors:  Su Mi Choi; Yonghak Kim; Hua Liu; Pooja Chaudhari; Zhaohui Ye; Yoon-Young Jang
Journal:  Cell Cycle       Date:  2011-08-01       Impact factor: 4.534

3.  Intratumoral versus intravenous gene therapy using a transcriptionally targeted viral vector in an orthotopic hepatocellular carcinoma rat model.

Authors:  Young Il Kim; Byeong-Cheol Ahn; John A Ronald; Regina Katzenberg; Abhinav Singh; Ramasamy Paulmurugan; Sunetra Ray; Sanjiv S Gambhir; Lawrence V Hofmann
Journal:  J Vasc Interv Radiol       Date:  2012-03-02       Impact factor: 3.464

4.  Establishment of NOD/SCID mouse models of human hepatocellular carcinoma via subcutaneous transplantation of histologically intact tumor tissue.

Authors:  Mingxia Yan; Hong Li; Fangyu Zhao; Lixing Zhang; Chao Ge; Ming Yao; Jinjun Li
Journal:  Chin J Cancer Res       Date:  2013-06       Impact factor: 5.087

5.  Suppression of the inflammatory cascade is implicated in resveratrol chemoprevention of experimental hepatocarcinogenesis.

Authors:  Anupam Bishayee; Abhijeet Waghray; Kendra F Barnes; Thomas Mbimba; Deepak Bhatia; Malay Chatterjee; Altaf S Darvesh
Journal:  Pharm Res       Date:  2010-04-20       Impact factor: 4.200

Review 6.  Hepatocellular carcinoma: insight from animal models.

Authors:  Yan Li; Zhao-You Tang; Jin-Xuan Hou
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-10-25       Impact factor: 46.802

7.  Establishment of an orthotopic transplantation tumor model of hepatocellular carcinoma in mice.

Authors:  Gui-Jun Zhao; Li-Xia Xu; Eagle S H Chu; Ning Zhang; Jia-Yun Shen; Alatangaole Damirin; Xiao-Xing Li
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

8.  Coronin-1C is a novel biomarker for hepatocellular carcinoma invasive progression identified by proteomics analysis and clinical validation.

Authors:  Long Wu; Chun-Wei Peng; Jin-Xuan Hou; Yan-Hua Zhang; Chuang Chen; Liang-Dong Chen; Yan Li
Journal:  J Exp Clin Cancer Res       Date:  2010-02-24

9.  Establishment of experimental implantation tumor models of hepatocellular carcinoma in Wistar rats.

Authors:  Yi Jin; Dayue Tong; Junjie Shen; Jianyong Yang; Jiaping Li
Journal:  Tumour Biol       Date:  2014-06-07

10.  Chemosensitization of HepG2 cells by suppression of NF-κB/p65 gene transcription with specific-siRNA.

Authors:  Yun Shi; Si-Ye Wang; Min Yao; Wen-Li Sai; Wei Wu; Jun-Ling Yang; Yin Cai; Wen-Jie Zheng; Deng-Fu Yao
Journal:  World J Gastroenterol       Date:  2015-12-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.